CLARIVATE PLC
Business
CLARIVATE PLC is a global provider of transformative intelligence that connects organizations to trusted data, analytics, workflow solutions, and expert services to support the innovation lifecycle. It offers enriched curated data collections, AI-enabled insights and analytics, automated workflow software, and specialist expert services such as consulting, patent and trademark maintenance and content products. The company operates three segments: Academia & Government; Intellectual Property; and Life Sciences & Healthcare. Clarivate serves universities, libraries, corporations, law firms, government agencies, and life‑science customers worldwide primarily via subscriptions, recurring contracts, and transactional sales.
Summary from filing dated 2025-02-19
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenues | 2,455 | 2,557 | 2,629 | 2,660 | 1,877 | |
| Cost of revenues | 834 | 869 | 906 | 954 | 626 | |
| Selling, general and administrative costs | 709 | 728 | 740 | 730 | 643 | |
| Depreciation and amortization | 757 | 727 | 708 | 711 | 538 | |
| Goodwill and intangible asset impairments | 15 | 541 | 980 | 4,449 | 0 | |
| Restructuring and other impairments | 51 | 20 | 40 | 67 | — | |
| Other operating expense (income), net | 19 | −52 | −11 | −325 | 28 | |
| Total operating expenses | 2,384 | 2,832 | 3,364 | 6,585 | 1,964 | |
| Income (loss) from operations | 72 | −276 | −735 | −3,926 | −87 | |
| Fair value adjustment of warrants | 0 | −5 | −16 | −207 | −81 | |
| Interest expense, net | 265 | 283 | 294 | 270 | — | |
| Income (loss) before income taxes | −194 | −554 | −1,013 | −3,989 | −258 | |
| Provision (benefit) for income taxes | 7 | 83 | −101 | −29 | 12 | |
| Net income (loss) | −201 | −637 | −911 | −3,960 | −271 | |
| Dividends on preferred shares | 0 | 31 | 75 | 75 | 42 | |
| Net income (loss) attributable to ordinary shares | −201 | −668 | −987 | −4,036 | −312 | |
| Basic (in dollars per share) | −0.3 | −0.96 | −1.47 | −5.97 | −0.49 | |
| Diluted (in dollars per share) | −0.3 | −0.96 | −1.47 | −6.24 | −0.61 | |
| Basic (in shares) | 673 | 694 | 672 | 676 | 631 | |
| Diluted (in shares) | 673 | 694 | 672 | 679 | 641 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents, including restricted cash | 329 | 295 | 371 | 357 | 431 | |
| Accounts receivable, net | 822 | 798 | 908 | 872 | 906 | |
| Prepaid expenses | 94 | 86 | 89 | 89 | 77 | |
| Other current assets | 65 | 65 | 68 | 77 | 67 | |
| Total current assets | 1,310 | 1,245 | 1,462 | 1,395 | 1,637 | |
| Property and equipment, net | 53 | 54 | 52 | 55 | 84 | |
| Other intangible assets, net | 8,008 | 8,441 | 9,007 | 9,438 | 10,392 | |
| Goodwill | 1,567 | 1,567 | 2,024 | 2,877 | 7,905 | |
| Other non-current assets | 68 | 82 | 61 | 98 | 51 | |
| Deferred income taxes | 17 | 49 | 47 | 24 | 28 | |
| Operating lease right-of-use assets | 47 | 54 | 55 | 59 | 86 | |
| Total assets | 11,069 | 11,490 | 12,707 | 13,945 | 20,183 | |
| Accounts payable | 151 | 125 | 144 | 101 | 129 | |
| Accrued compensation | 147 | 119 | 127 | 132 | 151 | |
| Accrued expenses and other current liabilities | 273 | 309 | 315 | 353 | 529 | |
| Current portion of deferred revenues | 879 | 859 | 983 | 948 | 1,030 | |
| Current portion of operating lease liability | 18 | 21 | 24 | 26 | 32 | |
| Total current liabilities | 1,569 | 1,434 | 1,600 | 1,560 | 1,902 | |
| Long-term debt | 4,322 | 4,519 | 4,721 | 5,005 | 5,456 | |
| Other non-current liabilities | 86 | 73 | 42 | 140 | 143 | |
| Deferred income taxes | 212 | 273 | 250 | 316 | 380 | |
| Operating lease liabilities | 38 | 53 | 63 | 73 | 94 | |
| Total liabilities | 6,227 | 6,351 | 6,715 | 7,132 | 8,257 | |
| Commitments and contingencies (Note 16) | — | — | — | — | — | |
| Ordinary Shares, no par value; unlimited shares authorized; 640.7 and 691.4 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 12,811 | 12,979 | 11,741 | 11,745 | 11,828 | |
| Accumulated other comprehensive loss | −453 | −526 | −495 | −666 | 327 | |
| Accumulated deficit | −7,515 | −7,314 | −6,646 | −5,659 | −1,604 | |
| Total shareholders' equity | 4,843 | 5,139 | 5,992 | 6,813 | 11,926 | |
| Total liabilities and shareholders' equity | 11,069 | 11,490 | 12,707 | 13,945 | 20,183 | |
| Current portion of long-term debt(1) | 102 | 1 | — | 1 | 31 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Share-based compensation | 63 | 60 | 109 | 94 | 33 | |
| Restructuring and other impairments, including goodwill | 19 | 540 | 986 | 4,479 | 48 | |
| Gain on sale from divestitures | 0 | −55 | 0 | −279 | 0 | |
| Gain on legal settlement | 0 | 0 | −49 | 0 | 0 | |
| Deferred income taxes | −42 | 21 | −78 | −54 | −13 | |
| Amortization and write-off of debt issuance costs | 14 | 16 | 18 | 16 | 13 | |
| Other operating activities | 14 | −2 | 22 | −18 | −12 | |
| Accounts receivable | −5 | 93 | −26 | −28 | −64 | |
| Prepaid expenses | −8 | 2 | 2 | −17 | 3 | |
| Other assets | 3 | −800,000 | 35 | −45 | 28 | |
| Accounts payable | 23 | −15 | 41 | −24 | 31 | |
| Accrued expenses and other current liabilities | −11 | 4 | −44 | −114 | 86 | |
| Deferred revenues | −3 | −106 | 20 | −9 | 200,000 | |
| Operating leases, net | −5 | −10 | −8 | −10 | −22 | |
| Other liabilities | 9 | 9 | −81 | −24 | 7 | |
| Net cash provided by operating activities | 629 | 647 | 744 | 509 | 324 | |
| Capital expenditures | −263 | −289 | −243 | −203 | −119 | |
| Payments to Acquire Businesses, Net of Cash Acquired | 0 | −32 | −5 | −25 | −3,930 | |
| Proceeds from divestitures, net of cash divested | 0 | 84 | 11 | 285 | 4 | |
| Net cash used for investing activities | −263 | −237 | −237 | 57 | −4,045 | |
| Principal payments on debt | −600 | −198 | −300 | −322 | −29 | |
| Proceeds from Issuance of Debt | 500 | 0 | 0 | — | — | |
| Payment of debt issuance and extinguishment costs | −9 | −20 | 100,000 | — | — | |
| Payments for Repurchase of Equity | 225 | 200 | 100 | 175 | −159 | |
| Cash dividends on preferred shares | 0 | −38 | −76 | −75 | −19 | |
| Payments related to tax withholding for share-based compensation | −10 | −16 | −21 | −15 | −25 | |
| Other financing activities | 1 | 1 | −500,000 | 5 | — | |
| Net cash used for financing activities | −343 | −470 | −497 | −759 | 4,032 | |
| Effects of exchange rates | 12 | −15 | 4 | −38 | 4 | |
| Net change in cash and cash equivalents, including restricted cash | 34 | −76 | 14 | −231 | 315 | |
| Cash paid for interest | 256 | 265 | 274 | 252 | 182 | |
| Cash paid for income tax | 42 | 53 | 43 | 64 | 34 |